tradingkey.logo
tradingkey.logo

Celltrion Announces U.S. Availability Of Avtozma® (Tocilizumab-Anoh) Subcutaneous (SC) Formulation

ReutersMar 16, 2026 12:16 PM

- Celltrion Inc 068270.KS:

  • CELLTRION ANNOUNCES U.S. AVAILABILITY OF AVTOZMA® (TOCILIZUMAB-ANOH) SUBCUTANEOUS (SC) FORMULATION

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI